177 related articles for article (PubMed ID: 36093484)
1. Nonalcoholic Fatty Liver Hepatocyte-Derived lncRNA MALAT1 Aggravates Pancreatic Cell Inflammation via the Inhibition of Autophagy by Upregulating YAP.
Liu D; Yao W; Liu K; Wang G; Chen B; Wang Z; Hou S
Comput Intell Neurosci; 2022; 2022():2930960. PubMed ID: 36093484
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal Feedback Loop of the MALAT1-MicroRNA-194-YAP1 Pathway Regulates Progression of Acute Pancreatitis.
Gu L; Liu J; Xu D; Lu Y
Med Sci Monit; 2019 Sep; 25():6894-6904. PubMed ID: 31518341
[TBL] [Abstract][Full Text] [Related]
3. Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling.
Zhou Y; Shan T; Ding W; Hua Z; Shen Y; Lu Z; Chen B; Dai T
J Cell Physiol; 2018 Aug; 233(8):5805-5814. PubMed ID: 29215734
[TBL] [Abstract][Full Text] [Related]
4. Emodin inhibits the progression of acute pancreatitis via regulation of lncRNA TUG1 and exosomal lncRNA TUG1.
Wen X; He B; Tang X; Wang B; Chen Z
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34498715
[TBL] [Abstract][Full Text] [Related]
5. ZNF143 inhibits hepatocyte mitophagy and promotes non-alcoholic fatty liver disease by targeting increased lncRNA NEAT1 expression to activate ROCK2 pathway.
Dong Y; Hu M; Tan K; Dai R
Epigenetics; 2023 Dec; 18(1):2239592. PubMed ID: 37566742
[TBL] [Abstract][Full Text] [Related]
6. Fatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase.
Salloum S; Jeyarajan AJ; Kruger AJ; Holmes JA; Shao T; Sojoodi M; Kim MH; Zhuo Z; Shroff SG; Kassa A; Corey KE; Khan SK; Lin W; Alatrakchi N; Schaefer EAK; Chung RT
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1297-1310. PubMed ID: 34118488
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells.
Leti F; Legendre C; Still CD; Chu X; Petrick A; Gerhard GS; DiStefano JK
Transl Res; 2017 Dec; 190():25-39.e21. PubMed ID: 28993096
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MALAT1 regulates diabetic cardiac fibroblasts through the Hippo-YAP signaling pathway.
Liu J; Xu L; Zhan X
Biochem Cell Biol; 2020 Oct; 98(5):537-547. PubMed ID: 32069074
[TBL] [Abstract][Full Text] [Related]
9. MALAT1 shuttled by extracellular vesicles promotes M1 polarization of macrophages to induce acute pancreatitis via miR-181a-5p/HMGB1 axis.
Liu J; Niu Z; Zhang R; Peng Z; Wang L; Liu Z; Gao Y; Pei H; Pan L
J Cell Mol Med; 2021 Oct; 25(19):9241-9254. PubMed ID: 34448533
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MALAT1 Promotes PPARα/CD36-Mediated Hepatic Lipogenesis in Nonalcoholic Fatty Liver Disease by Modulating miR-206/ARNT Axis.
Xiang J; Deng YY; Liu HX; Pu Y
Front Bioeng Biotechnol; 2022; 10():858558. PubMed ID: 35769097
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway.
Chi Y; Gong Z; Xin H; Wang Z; Liu Z
J Transl Med; 2020 Mar; 18(1):126. PubMed ID: 32169080
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of lncRNA NEAT1 Relieves Caerulein-Induced Cell Apoptosis and Inflammatory Injury in AR42J Cells Through Sponging miR-365a-3p in Acute Pancreatitis.
Shao A; Hu W; Li C; Yang Y; Zhu J
Biochem Genet; 2022 Dec; 60(6):2286-2298. PubMed ID: 35325441
[TBL] [Abstract][Full Text] [Related]
13. Retracted: Nonalcoholic Fatty Liver Hepatocyte-Derived lncRNA MALAT1 Aggravates Pancreatic Cell Inflammation via the Inhibition of Autophagy by Upregulating YAP.
Intelligence And Neuroscience C
Comput Intell Neurosci; 2023; 2023():9831369. PubMed ID: 37538718
[TBL] [Abstract][Full Text] [Related]
14. A tRNA-derived fragment (tRF-3001b) aggravates the development of nonalcoholic fatty liver disease by inhibiting autophagy.
Zhu J; Cheng M; Zhao X
Life Sci; 2020 Sep; 257():118125. PubMed ID: 32702444
[TBL] [Abstract][Full Text] [Related]
15. LncRNA MALAT1 cessation antagonizes hypoxia/reoxygenation injury in hepatocytes by inhibiting apoptosis and inflammation via the HMGB1-TLR4 axis.
Zhang Y; Zhang H; Zhang Z; Li S; Jiang W; Li X; Lv J
Mol Immunol; 2019 Aug; 112():22-29. PubMed ID: 31075559
[TBL] [Abstract][Full Text] [Related]
16. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
Liu J; Tang T; Wang GD; Liu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
[No Abstract] [Full Text] [Related]
17. Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathway.
Shen S; Wang K; Zhi Y; Shen W; Huang L
Cell Cycle; 2020 Nov; 19(22):3042-3053. PubMed ID: 33121337
[TBL] [Abstract][Full Text] [Related]
18. Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway.
Jin SS; Lin CJ; Lin XF; Zheng JZ; Guan HQ
Ann Hepatol; 2022; 27(2):100584. PubMed ID: 34808393
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin Attenuated Lipotoxicity via Autophagy Induction and Nuclear Factor-κB Inhibition.
Mao Y; Cheng J; Yu F; Li H; Guo C; Fan X
Cell Physiol Biochem; 2015; 37(2):563-76. PubMed ID: 26329041
[TBL] [Abstract][Full Text] [Related]
20. Silencing HIF-1α aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-α/ANGPTL4 singling pathway.
He Y; Yang W; Gan L; Liu S; Ni Q; Bi Y; Han T; Liu Q; Chen H; Hu Y; Long Y; Yang L
Gastroenterol Hepatol; 2021 May; 44(5):355-365. PubMed ID: 33272734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
